Advertisement

Topics

Merck Ventures Helps Launch New Immuno-Oncology Startup

15:00 EDT 21 Jun 2017 | Drug Discovery Development

iOnctura aims to develop a pipeline of selected assets that target and modulate mechanisms that drive immunosuppression in the tumor microenvironment.
Contributed Author: 
EMD Group
Topics: 

Original Article: Merck Ventures Helps Launch New Immuno-Oncology Startup

NEXT ARTICLE

More From BioPortfolio on "Merck Ventures Helps Launch New Immuno-Oncology Startup"

Advertisement
Quick Search
Advertisement
Advertisement